ABT
Price
$114.15
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
26 days until earnings call
RMD
Price
$242.98
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
34 days until earnings call
Ad is loading...

ABT vs RMD

Header iconABT vs RMD Comparison
Open Charts ABT vs RMDBanner chart's image
Abbott Laboratories
Price$114.15
Change-$0.00 (-0.00%)
Volume$8.14M
CapitalizationN/A
ResMed
Price$242.98
Change-$0.00 (-0.00%)
Volume$1.13M
CapitalizationN/A
View a ticker or compare two or three
ABT vs RMD Comparison Chart
Loading...
ABT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ABT vs. RMD commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Hold and RMD is a Hold.

COMPARISON
Comparison
Sep 21, 2024
Stock price -- (ABT: $114.88 vs. RMD: $238.03)
Brand notoriety: ABT: Notable vs. RMD: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 98% vs. RMD: 188%
Market capitalization -- ABT: $194.5B vs. RMD: $29.13B
ABT [@Medical Specialties] is valued at $194.5B. RMD’s [@Medical Specialties] market capitalization is $29.13B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 2 FA rating(s) are green whileRMD’s FA Score has 3 green FA rating(s).

  • ABT’s FA Score: 2 green, 3 red.
  • RMD’s FA Score: 3 green, 2 red.
According to our system of comparison, RMD is a better buy in the long-term than ABT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 4 TA indicator(s) are bullish while RMD’s TA Score has 3 bullish TA indicator(s).

  • ABT’s TA Score: 4 bullish, 5 bearish.
  • RMD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ABT is a better buy in the short-term than RMD.

Price Growth

ABT (@Medical Specialties) experienced а -1.48% price change this week, while RMD (@Medical Specialties) price change was -5.89% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.46%. For the same industry, the average monthly price growth was +0.65%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

ABT is expected to report earnings on Oct 16, 2024.

RMD is expected to report earnings on Oct 24, 2024.

Industries' Descriptions

@Medical Specialties (+1.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($194B) has a higher market cap than RMD($29.1B). ABT has higher P/E ratio than RMD: ABT (34.38) vs RMD (31.34). RMD YTD gains are higher at: 39.364 vs. ABT (5.953). ABT has higher annual earnings (EBITDA): 10.5B vs. RMD (1.43B). ABT has more cash in the bank: 7.28B vs. RMD (210M). RMD has less debt than ABT: RMD (1.39B) vs ABT (15.6B). ABT has higher revenues than RMD: ABT (40.1B) vs RMD (4.5B).
ABTRMDABT / RMD
Capitalization194B29.1B667%
EBITDA10.5B1.43B734%
Gain YTD5.95339.36415%
P/E Ratio34.3831.34110%
Revenue40.1B4.5B890%
Total Cash7.28B210M3,466%
Total Debt15.6B1.39B1,121%
FUNDAMENTALS RATINGS
ABT vs RMD: Fundamental Ratings
ABT
RMD
OUTLOOK RATING
1..100
1573
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
4145
SMR RATING
1..100
5842
PRICE GROWTH RATING
1..100
339
P/E GROWTH RATING
1..100
5824
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (12) in the Medical Specialties industry is in the same range as RMD (17). This means that ABT’s stock grew similarly to RMD’s over the last 12 months.

ABT's Profit vs Risk Rating (41) in the Medical Specialties industry is in the same range as RMD (45). This means that ABT’s stock grew similarly to RMD’s over the last 12 months.

RMD's SMR Rating (42) in the Medical Specialties industry is in the same range as ABT (58). This means that RMD’s stock grew similarly to ABT’s over the last 12 months.

RMD's Price Growth Rating (9) in the Medical Specialties industry is in the same range as ABT (33). This means that RMD’s stock grew similarly to ABT’s over the last 12 months.

RMD's P/E Growth Rating (24) in the Medical Specialties industry is somewhat better than the same rating for ABT (58). This means that RMD’s stock grew somewhat faster than ABT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTRMD
RSI
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
54%
MACD
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 10 days ago
66%
Declines
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 8 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Ad is loading...
ABT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGEN1.900.04
+2.15%
Compugen Ltd
DX12.820.04
+0.31%
Dynex Capital
GFI14.37-0.08
-0.55%
Gold Fields Ltd
GO16.47-0.36
-2.14%
Grocery Outlet Holding Corp
HCTI0.43-0.02
-5.37%
Healthcare Triangle

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
-2.75%
MDT - ABT
49%
Loosely correlated
-0.56%
SYK - ABT
47%
Loosely correlated
-0.71%
ZBH - ABT
45%
Loosely correlated
+0.04%
BSX - ABT
44%
Loosely correlated
+0.06%
SNN - ABT
44%
Loosely correlated
-0.81%
More

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with ABT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then ABT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
-5.12%
ABT - RMD
37%
Loosely correlated
-2.75%
SNN - RMD
37%
Loosely correlated
-0.81%
IDXX - RMD
36%
Loosely correlated
-0.19%
OSUR - RMD
36%
Loosely correlated
-1.82%
MDT - RMD
34%
Loosely correlated
-0.56%
More